Global Mucopolysaccharidosis II Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Mucopolysaccharidosis II Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Mucopolysaccharidosis II by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Mucopolysaccharidosis II by Country/Region, 2017, 2022 & 2028

2.2 Mucopolysaccharidosis II Segment by Type

2.2.1 JR-141

2.2.2 EGT-301

2.2.3 DUOC-01

2.2.4 AGT-182

2.2.5 JR-032

2.2.6 Others

2.3 Mucopolysaccharidosis II Sales by Type

2.3.1 Global Mucopolysaccharidosis II Sales Market Share by Type (2017-2022)

2.3.2 Global Mucopolysaccharidosis II Revenue and Market Share by Type (2017-2022)

2.3.3 Global Mucopolysaccharidosis II Sale Price by Type (2017-2022)

2.4 Mucopolysaccharidosis II Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Research Center

2.4.4 Others

2.5 Mucopolysaccharidosis II Sales by Application

2.5.1 Global Mucopolysaccharidosis II Sale Market Share by Application (2017-2022)

2.5.2 Global Mucopolysaccharidosis II Revenue and Market Share by Application (2017-2022)

2.5.3 Global Mucopolysaccharidosis II Sale Price by Application (2017-2022)

3 Global Mucopolysaccharidosis II by Company

3.1 Global Mucopolysaccharidosis II Breakdown Data by Company

3.1.1 Global Mucopolysaccharidosis II Annual Sales by Company (2020-2022)

3.1.2 Global Mucopolysaccharidosis II Sales Market Share by Company (2020-2022)

3.2 Global Mucopolysaccharidosis II Annual Revenue by Company (2020-2022)

3.2.1 Global Mucopolysaccharidosis II Revenue by Company (2020-2022)

3.2.2 Global Mucopolysaccharidosis II Revenue Market Share by Company (2020-2022)

3.3 Global Mucopolysaccharidosis II Sale Price by Company

3.4 Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Mucopolysaccharidosis II Product Location Distribution

3.4.2 Players Mucopolysaccharidosis II Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Mucopolysaccharidosis II by Geographic Region

4.1 World Historic Mucopolysaccharidosis II Market Size by Geographic Region (2017-2022)

4.1.1 Global Mucopolysaccharidosis II Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Mucopolysaccharidosis II Annual Revenue by Geographic Region

4.2 World Historic Mucopolysaccharidosis II Market Size by Country/Region (2017-2022)

4.2.1 Global Mucopolysaccharidosis II Annual Sales by Country/Region (2017-2022)

4.2.2 Global Mucopolysaccharidosis II Annual Revenue by Country/Region

4.3 Americas Mucopolysaccharidosis II Sales Growth

4.4 APAC Mucopolysaccharidosis II Sales Growth

4.5 Europe Mucopolysaccharidosis II Sales Growth

4.6 Middle East & Africa Mucopolysaccharidosis II Sales Growth

5 Americas

5.1 Americas Mucopolysaccharidosis II Sales by Country

5.1.1 Americas Mucopolysaccharidosis II Sales by Country (2017-2022)

5.1.2 Americas Mucopolysaccharidosis II Revenue by Country (2017-2022)

5.2 Americas Mucopolysaccharidosis II Sales by Type

5.3 Americas Mucopolysaccharidosis II Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Mucopolysaccharidosis II Sales by Region

6.1.1 APAC Mucopolysaccharidosis II Sales by Region (2017-2022)

6.1.2 APAC Mucopolysaccharidosis II Revenue by Region (2017-2022)

6.2 APAC Mucopolysaccharidosis II Sales by Type

6.3 APAC Mucopolysaccharidosis II Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Mucopolysaccharidosis II by Country

7.1.1 Europe Mucopolysaccharidosis II Sales by Country (2017-2022)

7.1.2 Europe Mucopolysaccharidosis II Revenue by Country (2017-2022)

7.2 Europe Mucopolysaccharidosis II Sales by Type

7.3 Europe Mucopolysaccharidosis II Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Mucopolysaccharidosis II by Country

8.1.1 Middle East & Africa Mucopolysaccharidosis II Sales by Country (2017-2022)

8.1.2 Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2017-2022)

8.2 Middle East & Africa Mucopolysaccharidosis II Sales by Type

8.3 Middle East & Africa Mucopolysaccharidosis II Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II

10.3 Manufacturing Process Analysis of Mucopolysaccharidosis II

10.4 Industry Chain Structure of Mucopolysaccharidosis II

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Mucopolysaccharidosis II Distributors

11.3 Mucopolysaccharidosis II Customer

12 World Forecast Review for Mucopolysaccharidosis II by Geographic Region

12.1 Global Mucopolysaccharidosis II Market Size Forecast by Region

12.1.1 Global Mucopolysaccharidosis II Forecast by Region (2023-2028)

12.1.2 Global Mucopolysaccharidosis II Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Mucopolysaccharidosis II Forecast by Type

12.7 Global Mucopolysaccharidosis II Forecast by Application

13 Key Players Analysis

13.1 Alexion Pharmaceuticals, Inc.

13.1.1 Alexion Pharmaceuticals, Inc. Company Information

13.1.2 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Offered

13.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Alexion Pharmaceuticals, Inc. Main Business Overview

13.1.5 Alexion Pharmaceuticals, Inc. Latest Developments

13.2 AngioChem Inc.

13.2.1 AngioChem Inc. Company Information

13.2.2 AngioChem Inc. Mucopolysaccharidosis II Product Offered

13.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AngioChem Inc. Main Business Overview

13.2.5 AngioChem Inc. Latest Developments

13.3 ArmaGen Inc.

13.3.1 ArmaGen Inc. Company Information

13.3.2 ArmaGen Inc. Mucopolysaccharidosis II Product Offered

13.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 ArmaGen Inc. Main Business Overview

13.3.5 ArmaGen Inc. Latest Developments

13.4 Bioasis Technologies Inc.

13.4.1 Bioasis Technologies Inc. Company Information

13.4.2 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Offered

13.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bioasis Technologies Inc. Main Business Overview

13.4.5 Bioasis Technologies Inc. Latest Developments

13.5 Green Cross Corporation

13.5.1 Green Cross Corporation Company Information

13.5.2 Green Cross Corporation Mucopolysaccharidosis II Product Offered

13.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Green Cross Corporation Main Business Overview

13.5.5 Green Cross Corporation Latest Developments

13.6 Inventiva

13.6.1 Inventiva Company Information

13.6.2 Inventiva Mucopolysaccharidosis II Product Offered

13.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Inventiva Main Business Overview

13.6.5 Inventiva Latest Developments

13.7 JCR Pharmaceuticals Co., Ltd.

13.7.1 JCR Pharmaceuticals Co., Ltd. Company Information

13.7.2 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Offered

13.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview

13.7.5 JCR Pharmaceuticals Co., Ltd. Latest Developments

13.8 Laboratorios Del Dr. Esteve S.A.

13.8.1 Laboratorios Del Dr. Esteve S.A. Company Information

13.8.2 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Offered

13.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Laboratorios Del Dr. Esteve S.A. Main Business Overview

13.8.5 Laboratorios Del Dr. Esteve S.A. Latest Developments

13.9 RegenxBio Inc.

13.9.1 RegenxBio Inc. Company Information

13.9.2 RegenxBio Inc. Mucopolysaccharidosis II Product Offered

13.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 RegenxBio Inc. Main Business Overview

13.9.5 RegenxBio Inc. Latest Developments

13.10 Sangamo BioSciences, Inc.

13.10.1 Sangamo BioSciences, Inc. Company Information

13.10.2 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Offered

13.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sangamo BioSciences, Inc. Main Business Overview

13.10.5 Sangamo BioSciences, Inc. Latest Developments

13.11 Takeda

13.11.1 Takeda Company Information

13.11.2 Takeda Mucopolysaccharidosis II Product Offered

13.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Takeda Main Business Overview

13.11.5 Takeda Latest Developments

14 Research Findings and Conclusion

Table 1. Mucopolysaccharidosis II Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Mucopolysaccharidosis II Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of JR-141

Table 4. Major Players of EGT-301

Table 5. Major Players of DUOC-01

Table 6. Major Players of AGT-182

Table 7. Major Players of JR-032

Table 8. Major Players of Others

Table 9. Global Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Mucopolysaccharidosis II Sales Market Share by Type (2017-2022)

Table 11. Global Mucopolysaccharidosis II Revenue by Type (2017-2022) & ($ million)

Table 12. Global Mucopolysaccharidosis II Revenue Market Share by Type (2017-2022)

Table 13. Global Mucopolysaccharidosis II Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Mucopolysaccharidosis II Sales Market Share by Application (2017-2022)

Table 16. Global Mucopolysaccharidosis II Revenue by Application (2017-2022)

Table 17. Global Mucopolysaccharidosis II Revenue Market Share by Application (2017-2022)

Table 18. Global Mucopolysaccharidosis II Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Mucopolysaccharidosis II Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Mucopolysaccharidosis II Sales Market Share by Company (2020-2022)

Table 21. Global Mucopolysaccharidosis II Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Mucopolysaccharidosis II Revenue Market Share by Company (2020-2022)

Table 23. Global Mucopolysaccharidosis II Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution and Sales Area

Table 25. Players Mucopolysaccharidosis II Products Offered

Table 26. Mucopolysaccharidosis II Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Mucopolysaccharidosis II Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Mucopolysaccharidosis II Sales Market Share Geographic Region (2017-2022)

Table 31. Global Mucopolysaccharidosis II Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Mucopolysaccharidosis II Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Mucopolysaccharidosis II Sales Market Share by Country/Region (2017-2022)

Table 35. Global Mucopolysaccharidosis II Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Mucopolysaccharidosis II Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Mucopolysaccharidosis II Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Mucopolysaccharidosis II Sales Market Share by Country (2017-2022)

Table 39. Americas Mucopolysaccharidosis II Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Mucopolysaccharidosis II Revenue Market Share by Country (2017-2022)

Table 41. Americas Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Mucopolysaccharidosis II Sales Market Share by Type (2017-2022)

Table 43. Americas Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Mucopolysaccharidosis II Sales Market Share by Application (2017-2022)

Table 45. APAC Mucopolysaccharidosis II Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Mucopolysaccharidosis II Sales Market Share by Region (2017-2022)

Table 47. APAC Mucopolysaccharidosis II Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Mucopolysaccharidosis II Revenue Market Share by Region (2017-2022)

Table 49. APAC Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Mucopolysaccharidosis II Sales Market Share by Type (2017-2022)

Table 51. APAC Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Mucopolysaccharidosis II Sales Market Share by Application (2017-2022)

Table 53. Europe Mucopolysaccharidosis II Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Mucopolysaccharidosis II Sales Market Share by Country (2017-2022)

Table 55. Europe Mucopolysaccharidosis II Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Mucopolysaccharidosis II Revenue Market Share by Country (2017-2022)

Table 57. Europe Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Mucopolysaccharidosis II Sales Market Share by Type (2017-2022)

Table 59. Europe Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Mucopolysaccharidosis II Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Mucopolysaccharidosis II Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis II

Table 70. Key Market Challenges & Risks of Mucopolysaccharidosis II

Table 71. Key Industry Trends of Mucopolysaccharidosis II

Table 72. Mucopolysaccharidosis II Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Mucopolysaccharidosis II Distributors List

Table 75. Mucopolysaccharidosis II Customer List

Table 76. Global Mucopolysaccharidosis II Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Mucopolysaccharidosis II Sales Market Forecast by Region

Table 78. Global Mucopolysaccharidosis II Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Mucopolysaccharidosis II Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Mucopolysaccharidosis II Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Mucopolysaccharidosis II Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Mucopolysaccharidosis II Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Mucopolysaccharidosis II Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Mucopolysaccharidosis II Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Mucopolysaccharidosis II Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Mucopolysaccharidosis II Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Mucopolysaccharidosis II Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Mucopolysaccharidosis II Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Mucopolysaccharidosis II Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Mucopolysaccharidosis II Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Mucopolysaccharidosis II Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Mucopolysaccharidosis II Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Mucopolysaccharidosis II Revenue Market Share Forecast by Application (2023-2028)

Table 96. Alexion Pharmaceuticals, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 97. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Offered

Table 98. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Alexion Pharmaceuticals, Inc. Main Business

Table 100. Alexion Pharmaceuticals, Inc. Latest Developments

Table 101. AngioChem Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 102. AngioChem Inc. Mucopolysaccharidosis II Product Offered

Table 103. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. AngioChem Inc. Main Business

Table 105. AngioChem Inc. Latest Developments

Table 106. ArmaGen Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 107. ArmaGen Inc. Mucopolysaccharidosis II Product Offered

Table 108. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. ArmaGen Inc. Main Business

Table 110. ArmaGen Inc. Latest Developments

Table 111. Bioasis Technologies Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 112. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Offered

Table 113. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Bioasis Technologies Inc. Main Business

Table 115. Bioasis Technologies Inc. Latest Developments

Table 116. Green Cross Corporation Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 117. Green Cross Corporation Mucopolysaccharidosis II Product Offered

Table 118. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Green Cross Corporation Main Business

Table 120. Green Cross Corporation Latest Developments

Table 121. Inventiva Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 122. Inventiva Mucopolysaccharidosis II Product Offered

Table 123. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Inventiva Main Business

Table 125. Inventiva Latest Developments

Table 126. JCR Pharmaceuticals Co., Ltd. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 127. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Offered

Table 128. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. JCR Pharmaceuticals Co., Ltd. Main Business

Table 130. JCR Pharmaceuticals Co., Ltd. Latest Developments

Table 131. Laboratorios Del Dr. Esteve S.A. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 132. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Offered

Table 133. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Laboratorios Del Dr. Esteve S.A. Main Business

Table 135. Laboratorios Del Dr. Esteve S.A. Latest Developments

Table 136. RegenxBio Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 137. RegenxBio Inc. Mucopolysaccharidosis II Product Offered

Table 138. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. RegenxBio Inc. Main Business

Table 140. RegenxBio Inc. Latest Developments

Table 141. Sangamo BioSciences, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 142. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Offered

Table 143. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Sangamo BioSciences, Inc. Main Business

Table 145. Sangamo BioSciences, Inc. Latest Developments

Table 146. Takeda Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors

Table 147. Takeda Mucopolysaccharidosis II Product Offered

Table 148. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. Takeda Main Business

Table 150. Takeda Latest Developments

List of Figures

Figure 1. Picture of Mucopolysaccharidosis II

Figure 2. Mucopolysaccharidosis II Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Mucopolysaccharidosis II Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Mucopolysaccharidosis II Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Mucopolysaccharidosis II Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of JR-141

Figure 10. Product Picture of EGT-301

Figure 11. Product Picture of DUOC-01

Figure 12. Product Picture of AGT-182

Figure 13. Product Picture of JR-032

Figure 14. Product Picture of Others

Figure 15. Global Mucopolysaccharidosis II Sales Market Share by Type in 2021

Figure 16. Global Mucopolysaccharidosis II Revenue Market Share by Type (2017-2022)

Figure 17. Mucopolysaccharidosis II Consumed in Hospital

Figure 18. Global Mucopolysaccharidosis II Market: Hospital (2017-2022) & (K Pcs)

Figure 19. Mucopolysaccharidosis II Consumed in Clinic

Figure 20. Global Mucopolysaccharidosis II Market: Clinic (2017-2022) & (K Pcs)

Figure 21. Mucopolysaccharidosis II Consumed in Research Center

Figure 22. Global Mucopolysaccharidosis II Market: Research Center (2017-2022) & (K Pcs)

Figure 23. Mucopolysaccharidosis II Consumed in Others

Figure 24. Global Mucopolysaccharidosis II Market: Others (2017-2022) & (K Pcs)

Figure 25. Global Mucopolysaccharidosis II Sales Market Share by Application (2017-2022)

Figure 26. Global Mucopolysaccharidosis II Revenue Market Share by Application in 2021

Figure 27. Mucopolysaccharidosis II Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Mucopolysaccharidosis II Revenue Market Share by Company in 2021

Figure 29. Global Mucopolysaccharidosis II Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region in 2021

Figure 31. Global Mucopolysaccharidosis II Sales Market Share by Region (2017-2022)

Figure 32. Global Mucopolysaccharidosis II Revenue Market Share by Country/Region in 2021

Figure 33. Americas Mucopolysaccharidosis II Sales 2017-2022 (K Pcs)

Figure 34. Americas Mucopolysaccharidosis II Revenue 2017-2022 ($ Millions)

Figure 35. APAC Mucopolysaccharidosis II Sales 2017-2022 (K Pcs)

Figure 36. APAC Mucopolysaccharidosis II Revenue 2017-2022 ($ Millions)

Figure 37. Europe Mucopolysaccharidosis II Sales 2017-2022 (K Pcs)

Figure 38. Europe Mucopolysaccharidosis II Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Mucopolysaccharidosis II Sales 2017-2022 (K Pcs)

Figure 40. Middle East & Africa Mucopolysaccharidosis II Revenue 2017-2022 ($ Millions)

Figure 41. Americas Mucopolysaccharidosis II Sales Market Share by Country in 2021

Figure 42. Americas Mucopolysaccharidosis II Revenue Market Share by Country in 2021

Figure 43. United States Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Mucopolysaccharidosis II Sales Market Share by Region in 2021

Figure 48. APAC Mucopolysaccharidosis II Revenue Market Share by Regions in 2021

Figure 49. China Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Mucopolysaccharidosis II Sales Market Share by Country in 2021

Figure 56. Europe Mucopolysaccharidosis II Revenue Market Share by Country in 2021

Figure 57. Germany Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country in 2021

Figure 64. Egypt Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Mucopolysaccharidosis II Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II in 2021

Figure 70. Manufacturing Process Analysis of Mucopolysaccharidosis II

Figure 71. Industry Chain Structure of Mucopolysaccharidosis II

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles